<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="sca-io" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">sca-io</book-part-id>
      <title-group>
        <title>Infantile-Onset Spinocerebellar Ataxia</title>
        <alt-title alt-title-type="alt-title">Synonym: IOSCA</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Nikali</surname>
            <given-names>Kaisu</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Research Associate, Institute of Child Health<break/>University College London<break/>London, United Kingdom</aff>
          <email>knikali@o2.co.uk</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>L&#x000f6;nnqvist</surname>
            <given-names>Tuula</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Assistant Professor, Department of Child Neurology<break/>Hospital for Children and Adolescents<break/>Helsinki University Central Hospital<break/>Helsinki, Finland</aff>
          <email>tuula.lonnqvist@hus.fi</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>27</day>
          <month>1</month>
          <year>2009</year>
        </date>
        <date date-type="updated">
          <day>15</day>
          <month>1</month>
          <year>2015</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="i-p" document-type="chapter">Incontinentia Pigmenti</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="kms" document-type="chapter">Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency</related-object>
      <abstract id="sca-io.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Infantile-onset spinocerebellar ataxia (IOSCA) is a severe, progressive neurodegenerative disorder characterized by normal development until age one year, followed by onset of ataxia, muscle hypotonia, loss of deep-tendon reflexes, and athetosis. Ophthalmoplegia and sensorineural deafness develop by age seven years. By adolescence affected individuals are profoundly deaf and no longer ambulatory; sensory axonal neuropathy, optic atrophy, autonomic nervous system dysfunction, and hypergonadotropic hypogonadism in females become evident. Epilepsy can develop into a serious and often fatal encephalopathy: myoclonic jerks or focal clonic seizures that progress to epilepsia partialis continua followed by status epilepticus with loss of consciousness.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis is based on clinical findings and can be confirmed by the presence of pathogenic variants in <italic toggle="yes">TWNK</italic> (previously <italic toggle="yes">C10orf2</italic>, <italic toggle="yes">PEO1</italic>), the only gene known to be associated with IOSCA.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Hearing loss, sensory axonal neuropathy, ataxia, psychotic behavior, and severe depression are treated in the usual manner. Conventional antiepileptic drugs (AEDs) (phenytoin and phenobarbital) are ineffective in most affected individuals.</p>
          <p><italic toggle="yes">Surveillance:</italic> Small children: neurologic, audiologic, and ophthalmologic evaluations every six to 12 months; neurophysiologic studies when indicated; brain MRI every three to five years. Adolescents and adults: neurologic examination yearly; audiologic and ophthalmologic examinations every one to two years; EEG and brain MRI at least during status epilepticus.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Valproate, which can cause significant elevation of serum concentration of bilirubin and liver enzymes.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>IOSCA is inherited in an autosomal recessive manner. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and prenatal diagnosis for pregnancies at increased risk are possible if the pathogenic variants in the family are known.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="sca-io.Diagnosis">
        <title>Diagnosis</title>
        <sec id="sca-io.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>The diagnostic criteria for infantile-onset spinocerebellar ataxia (IOSCA) were detailed by <xref ref-type="bibr" rid="sca-io.REF.koskinen.1994a.509">Koskinen et al [1994a]</xref> and <xref ref-type="bibr" rid="sca-io.REF.koskinen.1994b.50">Koskinen et al [1994b]</xref>. After normal early development, children with IOSCA typically present in successive order from the second year of life onward with the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Spinocerebellar ataxia</p>
            </list-item>
            <list-item>
              <p>Muscle hypotonia</p>
            </list-item>
            <list-item>
              <p>Athetoid movements</p>
            </list-item>
            <list-item>
              <p>Loss of deep-tendon reflexes</p>
            </list-item>
            <list-item>
              <p>Hearing deficit</p>
            </list-item>
            <list-item>
              <p>Ophthalmoplegia</p>
            </list-item>
            <list-item>
              <p>Optic atrophy</p>
            </list-item>
            <list-item>
              <p>Epileptic encephalopathy</p>
            </list-item>
            <list-item>
              <p>Female primary hypergonadotropic hypogonadism</p>
            </list-item>
          </list>
          <p>The diagnosis is based on typical clinical findings and can be confirmed by molecular genetic testing (see <xref ref-type="sec" rid="sca-io.Testing_Strategy">Testing Strategy</xref>).</p>
        </sec>
        <sec id="sca-io.Testing">
          <title>Testing</title>
          <p>All routine laboratory and metabolic screening tests are normal.</p>
          <p>Muscle morphology and respiratory chain enzyme analyses are normal.</p>
          <p>Mitochondrial DNA (mtDNA) deletion and/or depletion are not identified in muscle of individuals with IOSCA; however:</p>
          <list list-type="bullet">
            <list-item>
              <p>Mitochondrial DNA depletion has been shown in the liver of a few compound heterozygotes [<xref ref-type="bibr" rid="sca-io.REF.hakonen.2007.3032">Hakonen et al 2007</xref>];</p>
            </list-item>
            <list-item>
              <p>Post-mortem material has revealed complex I (CI) deficiency and mtDNA depletion in the brain [<xref ref-type="bibr" rid="sca-io.REF.hakonen.2008.3822">Hakonen et al 2008</xref>].</p>
            </list-item>
          </list>
          <sec id="sca-io.Molecular_Genetic_Testing">
            <title>Molecular Genetic Testing</title>
            <p><bold>Gene.</bold>
<italic toggle="yes">TWNK</italic> (previously <italic toggle="yes">C10orf2, PEO1</italic>) is the only gene implicated in the pathogenesis of IOSCA [<xref ref-type="bibr" rid="sca-io.REF.nikali.1995.1088">Nikali et al 1995</xref>, <xref ref-type="bibr" rid="sca-io.REF.nikali.2005.2981">Nikali et al 2005</xref>].</p>
            <table-wrap id="sca-io.T.summary_of_molecular_genetic_te" orientation="portrait" position="anchor">
              <label>Table 1. </label>
              <caption>
                <p>Summary of Molecular Genetic Testing Used in Infantile-Onset Spinocerebellar Ataxia</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_sca-io.T.summary_of_molecular_genetic_te_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_sca-io.T.summary_of_molecular_genetic_te_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                    <th id="hd_h_sca-io.T.summary_of_molecular_genetic_te_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant Detectable by This Method</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_sca-io.T.summary_of_molecular_genetic_te_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1"><italic toggle="yes">TWNK</italic> (<italic toggle="yes">C10orf2</italic>, <italic toggle="yes">PEO1</italic>)</td>
                    <td headers="hd_h_sca-io.T.summary_of_molecular_genetic_te_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Targeted analysis for <xref ref-type="table" rid="sca-io.T.selected_twnk_c10orf2_pathogeni">c.1523A&#x0003e;G</xref>&#x000a0;<sup>2</sup></td>
                    <td headers="hd_h_sca-io.T.summary_of_molecular_genetic_te_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">100%&#x000a0;<sup>3</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_sca-io.T.summary_of_molecular_genetic_te_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Sequence analysis&#x000a0;<sup>4</sup></td>
                    <td headers="hd_h_sca-io.T.summary_of_molecular_genetic_te_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">100%&#x000a0;<sup>5,&#x000a0;6</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_sca-io.T.summary_of_molecular_genetic_te_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>7</sup></td>
                    <td headers="hd_h_sca-io.T.summary_of_molecular_genetic_te_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">None reported</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="sca-io.TF.1.1">
                  <label>1. </label>
                  <p>See <related-object source-id="gene" document-id="sca-io" object-id="sca-io.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. See <xref ref-type="sec" rid="sca-io.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
                </fn>
                <fn id="sca-io.TF.1.2">
                  <label>2. </label>
                  <p>Note: Pathogenic variants included in a panel may vary by laboratory. The most common pathogenic variant in IOSCA is the Finnish founder variant <xref ref-type="table" rid="sca-io.T.selected_twnk_c10orf2_pathogeni">c.1523A&#x0003e;G</xref> in exon 3 of <italic toggle="yes">TWNK</italic> [<xref ref-type="bibr" rid="sca-io.REF.nikali.2005.2981">Nikali et al 2005</xref>].</p>
                </fn>
                <fn id="sca-io.TF.1.3">
                  <label>3. </label>
                  <p>IOSCA, a representative of Finnish disease heritage, is typically not found elsewhere in the world.</p>
                </fn>
                <fn id="sca-io.TF.1.4">
                  <label>4. </label>
                  <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="sca-io.TF.1.5">
                  <label>5. </label>
                  <p>In the exon/flanking intron regions sequenced; pathogenic variants in non-sequenced intronic and regulatory regions are not detected.</p>
                </fn>
                <fn id="sca-io.TF.1.6">
                  <label>6. </label>
                  <p>Sequence analysis detects other variants including the two other known single-nucleotide variants, <xref ref-type="table" rid="sca-io.T.selected_twnk_c10orf2_pathogeni">c.1287C&#x0003e;T</xref> and <xref ref-type="table" rid="sca-io.T.selected_twnk_c10orf2_pathogeni">c.952G&#x0003e;A</xref>. These have been observed in the compound heterozygous state (i.e., c.[1523A&#x0003e;G]+[1287C&#x0003e;T] and c.[1523A&#x0003e;G]+[952G&#x0003e;A]) in one and two affected individuals, respectively [<xref ref-type="bibr" rid="sca-io.REF.nikali.2005.2981">Nikali et al 2005</xref>, <xref ref-type="bibr" rid="sca-io.REF.hakonen.2007.3032">Hakonen et al 2007</xref>].</p>
                </fn>
                <fn id="sca-io.TF.1.7">
                  <label>7. </label>
                  <p>Testing that identifies exon or whole-gene deletions/duplications not detectable by sequence analysis of the coding and flanking intron regions of genomic DNA. Included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
        </sec>
        <sec id="sca-io.Testing_Strategy">
          <title>Testing Strategy</title>
          <p><bold>Confirming the diagnosis in a proband.</bold> The diagnosis is based on typical clinical findings and can be confirmed by the identification of one of the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Homozygosity of the founder IOSCA-causing variant in <italic toggle="yes">TWNK</italic> (<italic toggle="yes">C10orf2</italic>)</p>
            </list-item>
            <list-item>
              <p>Compound heterozygosity for the founder IOSCA-causing variant in <italic toggle="yes">TWNK</italic> and another pathogenic variant</p>
            </list-item>
          </list>
          <p><bold>An alternative genetic testing strategy</bold> is use of a multi-gene panel that includes <italic toggle="yes">TWNK</italic> and other genes of interest (see <xref ref-type="sec" rid="sca-io.Differential_Diagnosis">Differential Diagnosis</xref>). Note: The genes included and the methods used in multi-gene panels vary by laboratory and over time.</p>
          <p>For more information on multi-gene panels click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.MultiGene_Panels" object-type="sec">here</related-object>.</p>
          <p><bold>More comprehensive genomic testing</bold> (when available) including exome sequencing, mitochondrial sequencing, and genome sequencing may be considered if serial single-gene testing (and/or use of a multi-gene panel that includes <italic toggle="yes">TWNK</italic>) fails to confirm a diagnosis in an individual with features of IOSCA. For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
        </sec>
      </sec>
      <sec id="sca-io.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="sca-io.Clinical_Description">
          <title>Clinical Description</title>
          <p>Infantile-onset spinocerebellar ataxia (IOSCA) is a severe, progressive neurodegenerative disorder [<xref ref-type="bibr" rid="sca-io.REF.koskinen.1994b.50">Koskinen et al 1994b</xref>]. Affected children are born after an uneventful pregnancy and develop normally until age one year, when the first clinical symptoms of ataxia, muscle hypotonia, loss of deep-tendon reflexes, and athetosis appear. Ophthalmoplegia and sensorineural deafness develop by school age (age 7 years). By adolescence sensory axonal neuropathy, optic atrophy, and hypergonadotropic hypogonadism in females become evident. Migraine, psychiatric symptoms, and epilepsy are late manifestations.</p>
          <p>By adolescence affected individuals are no longer ambulatory, being dependent on either a walker or wheelchair. The hearing deficit is severe (&#x0003e;100 dB) and communication relies on sign language. Progressive pes cavus foot deformity and neurogenic scoliosis are common, as well as autonomic nervous system dysfunction, which manifests as increased perspiration, difficulty with urination and/or urinary incontinence, and obstipation.</p>
          <p>The supratentorial brain (i.e., cerebral cortex, cerebral white matter, basal ganglia, and other deep brain nuclei) is well preserved until the onset of epilepsy. In 15 children, epilepsy developed into a serious encephalopathy, beginning at ages two and four years in compound heterozygotes and between ages 15 and 34 years (mean age 24 years) in homozygotes. The seizures were myoclonic jerks or focal clonic seizures that progressed to epilepsia partialis continua and further to status epilepticus with loss of consciousness and tonic-clonic seizures. Death of nine of these 15 individuals was directly or indirectly related to epilepsy.</p>
          <p>The supratentorial findings of cortical edema and later cortical and central atrophy appear at the time of and after the onset of epilepsy.</p>
          <p>The cortical edema is of a non-vascular distribution. The area of swollen cortex varied from multiple small lesions to the involvement of the whole hemisphere, thalamus, and caudate nucleus. In diffusion-weighted imaging (DWI), the lesions showed restricted diffusion, thus behaving like early ischemic changes. Some of these lesions were reversible, but a T<sub>1</sub>-weighted hyperintense cortical signal compatible with cortical laminar necrosis developed in individuals with recurrent status epilepticus. Supratentorial cortical and central atrophy was seen in all individuals with intractable status epilepticus, but not in children or adults without refractory epilepsy. Epileptic encephalopathy in IOSCA is similar to that seen in other mitochondrial disorders, including <related-object link-type="booklink" source-id="gene" document-id="melas" document-type="chapter">MELAS</related-object>.</p>
          <p><bold>Neuroimaging.</bold> Spinocerebellar degeneration progresses gradually with increasing age. Serial MRI reveal cerebellar, cortical, and brain stem atrophy with increased signal intensity in the cerebellar white matter on T<sub>2</sub>-weighted images [<xref ref-type="bibr" rid="sca-io.REF.koskinen.1995b.1427">Koskinen et al 1995b</xref>].</p>
          <p><bold>Neuropathology.</bold> Post-mortem studies show moderate brain stem and cerebellar atrophy and severe atrophic changes in the dorsal roots, posterior columns, and posterior spinocerebellar tracts of the spinal cord [<xref ref-type="bibr" rid="sca-io.REF.koskinen.1994a.509">Koskinen et al 1994a</xref>, <xref ref-type="bibr" rid="sca-io.REF.l_nnqvist.1998.57">L&#x000f6;nnqvist et al 1998</xref>].</p>
        </sec>
        <sec id="sca-io.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p><bold>Classic IOSCA.</bold> Within and between families, individuals with IOSCA who are homozygous for the c.1523A&#x0003e;G founder variant show similar early-onset symptoms and clinical course, except for the onset of epilepsy [<xref ref-type="bibr" rid="sca-io.REF.koskinen.1994b.50">Koskinen et al 1994b</xref>]. The c.[<xref ref-type="table" rid="sca-io.T.selected_twnk_c10orf2_pathogeni">1523A&#x0003e;G</xref>]+[<xref ref-type="table" rid="sca-io.T.selected_twnk_c10orf2_pathogeni">1287C&#x0003e;T</xref>] compound heterozygote, whose paternal c.1287C&#x0003e;T disease allele is expressed in a greatly reduced level, shows a phenotype similar to c.1523A&#x0003e;G homozygotes. Small amounts of normal <italic toggle="yes">TWNK</italic> (<italic toggle="yes">C10orf2</italic>) transcripts are thus not sufficient to rescue the IOSCA phenotype caused by the c.1523A&#x0003e;G pathogenic variant, whereas a full amount of mRNAs expressed from at least one normal allele is required to preserve the development of a healthy individual [<xref ref-type="bibr" rid="sca-io.REF.nikali.2005.2981">Nikali et al 2005</xref>].</p>
          <p><bold>Atypical IOSCA.</bold> The clinical course is more rapid and severe in c.[<xref ref-type="table" rid="sca-io.T.selected_twnk_c10orf2_pathogeni">1523A&#x0003e;G</xref>]+[<xref ref-type="table" rid="sca-io.T.selected_twnk_c10orf2_pathogeni">952G&#x0003e;A</xref>] compound heterozygotes and is characterized by severe early-onset encephalopathy and signs of liver involvement. The clinical manifestations include hypotonia, athetosis, sensory neuropathy, ataxia, hearing deficit, ophthalmoplegia, intractable epilepsy, and elevation of serum transaminases. The liver shows mtDNA depletion, whereas the muscle mtDNA is only slightly affected. These compound heterozygous individuals died at age 4.5 years, whereas the oldest homozygous individual (without epilepsy) is alive at age 50 years.</p>
        </sec>
        <sec id="sca-io.Penetrance">
          <title>Penetrance</title>
          <p>Penetrance is complete in both homozygotes and compound heterozygotes.</p>
        </sec>
        <sec id="sca-io.Nomenclature">
          <title>Nomenclature</title>
          <p>IOSCA was originally known as OHAHA (<italic toggle="yes">o</italic>phthalmoplegia, <italic toggle="yes">h</italic>ypoacusis, <italic toggle="yes">a</italic>taxia, <italic toggle="yes">h</italic>ypotonia, <italic toggle="yes">a</italic>thetosis) syndrome [<xref ref-type="bibr" rid="sca-io.REF.kallio.1985.84">Kallio &#x00026; Jauhiainen 1985</xref>].</p>
        </sec>
        <sec id="sca-io.Prevalence">
          <title>Prevalence</title>
          <p>To date, 24 individuals with IOSCA have been identified:</p>
          <list list-type="bullet">
            <list-item>
              <p>21 homozygotes: c.[<xref ref-type="table" rid="sca-io.T.selected_twnk_c10orf2_pathogeni">1523A&#x0003e;G</xref>]+[1523A&#x0003e;G]</p>
            </list-item>
            <list-item>
              <p>Two compound heterozygotes: c.[1523A&#x0003e;G]+[<xref ref-type="table" rid="sca-io.T.selected_twnk_c10orf2_pathogeni">952G&#x0003e;A</xref>]</p>
            </list-item>
            <list-item>
              <p>One compound heterozygote: c.[1523A&#x0003e;G]+[<xref ref-type="table" rid="sca-io.T.selected_twnk_c10orf2_pathogeni">1287C&#x0003e;T</xref>]</p>
            </list-item>
          </list>
          <p>All individuals with IOSCA have been identified in the genetically isolated population of Finland, where IOSCA is the second-most common inherited ataxia. No individuals with IOSCA have been reported outside Finland [<xref ref-type="bibr" rid="sca-io.REF.nikali.2005.2981">Nikali et al 2005</xref>].</p>
          <p>The carrier frequency of the c.1523A&#x0003e;G founder variant varies between 0.44% (1:230) in all of Finland and 2.0%-2.4% (1:50-1:40) in selected subisolates in Ostrobothnia and Savo. The other two pathogenic variants observed in the compound heterozygous individuals have been identified only in the families reported.</p>
        </sec>
      </sec>
      <sec id="sca-io.Genetically_Related_Allelic_Disor">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>IOSCA is allelic to several disorders caused by distinct <italic toggle="yes">TWNK</italic> (<italic toggle="yes">C10orf2</italic>) pathogenic variants, two inherited in an autosomal dominant and two in an autosomal recessive manner.</p>
        <p><bold>Autosomal dominant progressive external ophthalmoplegia</bold>
<bold>(adPEO)</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/609286">609286</ext-link>) is a heterogeneous late-onset neuromuscular disorder sharing a spectrum of findings with IOSCA but characterized by accumulation of multiple deletions of mtDNA in muscle, brain, and heart. Typical clinical findings include exercise intolerance, muscle weakness, peripheral neuropathy, deafness, ataxia, and cataracts. In addition, psychiatric problems can occur [<xref ref-type="bibr" rid="sca-io.REF.zeviani.1989.309">Zeviani et al 1989</xref>, <xref ref-type="bibr" rid="sca-io.REF.suomalainen.1992.61">Suomalainen et al 1992</xref>].</p>
        <p>Several distinct dominant <italic toggle="yes">TWNK</italic> pathogenic variants have been observed in unrelated families with adPEO of different ethnic origins [<xref ref-type="bibr" rid="sca-io.REF.spelbrink.2001.223">Spelbrink et al 2001</xref>, <xref ref-type="bibr" rid="sca-io.REF.kiechl.2004.1125">Kiechl et al 2004</xref>, <xref ref-type="bibr" rid="sca-io.REF.jeppesen.2008.306">Jeppesen et al 2008</xref>, <xref ref-type="bibr" rid="sca-io.REF.virgilio.2008.1384">Virgilio et al 2008</xref>].</p>
        <p>In addition:</p>
        <list list-type="bullet">
          <list-item>
            <p>A novel heterozygous <italic toggle="yes">TWNK</italic> pathogenic variant has been observed in a three-generation family in which affected individuals developed parkinsonism responsive for dopamine replacement treatment ten to 20 years after the onset of PEO [<xref ref-type="bibr" rid="sca-io.REF.baloh.2007.998">Baloh et al 2007</xref>].</p>
          </list-item>
          <list-item>
            <p>In one Spanish family, two elderly individuals who had a mild phenotype of autosomal dominant ocular myopathy and muscle morphologic mitochondrial abnormalities were shown to have a de novo pathogenic variant in the <italic toggle="yes">TWNK</italic> region that encodes the primase/helicase linker of the protein product, Twinkle [<xref ref-type="bibr" rid="sca-io.REF.rivera.2007.677">Rivera et al 2007</xref>].</p>
          </list-item>
          <list-item>
            <p>A novel heterozygous <italic toggle="yes">TWNK</italic> pathogenic variant in the linker region of Twinkle was identified in a highly consanguineous four-generation Saudi Arabian family. The clinical features in this family are unusual, in that common adPEO features are accompanied by life-threatening multi-organ failure in a later disease stage [<xref ref-type="bibr" rid="sca-io.REF.bohlega.2009.845">Bohlega et al 2009</xref>].</p>
          </list-item>
          <list-item>
            <p>AdPEO-causing pathogenic variants in the linker region of Twinkle invariably result in mtDNA deletions caused by impaired hexamerization of the multimer helicase activity and, thus, a phenotype different from IOSCA.</p>
          </list-item>
        </list>
        <p><bold>Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis</bold>
<bold>(SANDO)</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/607459">607459</ext-link>) can be caused by a heterozygous <xref ref-type="table" rid="sca-io.T.selected_twnk_c10orf2_pathogeni">c.955A&#x0003e;G</xref> transition <italic toggle="yes">TWNK</italic> pathogenic variant that results in a <xref ref-type="table" rid="sca-io.T.selected_twnk_c10orf2_pathogeni">p.Lys319Glu</xref> substitution in the corresponding proteins. The heterozygous pathogenic variant was observed in two sibs: one with SANDO and one with sensory ataxic neuropathy and ophthalmoparesis, but no dysarthria. The pathogenic variant was not detected in the blood, hair, urinary epithelium, or buccal mucosa of either parent, indicating germline mosaicism [<xref ref-type="bibr" rid="sca-io.REF.hudson.2005.371">Hudson et al 2005</xref>].</p>
        <p><bold>Hepatocerebral form of mtDNA depletion syndrome</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/606075">606075</ext-link>) is a recessively inherited, heterogeneous disease characterized by neonatal hypotonia, mild liver insufficiency, increased serum and cerebrospinal fluid (CSF) concentrations of lactate, psychomotor retardation, seizures, and peripheral neuropathy. It was associated with a homozygous <xref ref-type="table" rid="sca-io.T.selected_twnk_c10orf2_pathogeni">c.1370C&#x0003e;T</xref> transition (p.Thr457Ile) variant in <italic toggle="yes">TWNK</italic> in three individuals from Algeria born to consanguineous parents. The pathogenic variant was shown to cause mtDNA depletion via a defect in the helicase activity of Twinkle [<xref ref-type="bibr" rid="sca-io.REF.sarzi.2007.579">Sarzi et al 2007</xref>].</p>
        <p><bold>A novel allelic ataxia condition.</bold>
<xref ref-type="bibr" rid="sca-io.REF.park.2014.171">Park et al [2014]</xref> reported a Korean family with two affected individuals who were found through exome sequencing to have compound heterozygous pathogenic variants (c.1460C&#x0003e;T and c.1485-1G&#x0003e;A) in <italic toggle="yes">TWNK</italic>. The IOSCA-causing Finnish founder variant (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://omim.org/entry/606075">606075</ext-link>) was not detected. The Korean disease phenotype shares many clinical features with IOSCA, but also includes myopathy and mtDNA deletions in skeletal muscle, neither of which is typical in IOSCA. Neither of the affected individuals from this Korean family has developed epileptic encephalopathy, a typical feature in IOSCA [<xref ref-type="bibr" rid="sca-io.REF.park.2014.171">Park et al 2014</xref>]. Therefore, this may represent a newly recognized autosomal recessive condition.</p>
      </sec>
      <sec id="sca-io.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Differential diagnosis for infantile-onset spinocerebellar ataxia (IOSCA) or at least for recessive <italic toggle="yes">TWNK</italic> (<italic toggle="yes">C10orf2</italic>) pathogenic variants should be considered for all early-onset cerebellar ataxias with sensory axonal neuropathy and epileptic encephalopathy.</p>
        <p>The spinocerebellar degeneration in IOSCA is similar to that in <related-object link-type="booklink" source-id="gene" document-id="friedreich" document-type="chapter">Friedreich ataxia</related-object> (FA) and other mitochondrial disorders with axonal neuropathy.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="alpers" document-type="chapter"><bold><italic toggle="yes">POLG-</italic>related disorders</bold></related-object><bold>.</bold>
<italic toggle="yes">POLG</italic> (previously <italic toggle="yes">POLG1</italic>), a nuclear gene that encodes mitochondrial DNA polymerase gamma is a functional partner of Twinkle in the mtDNA replication fork [<xref ref-type="bibr" rid="sca-io.REF.hakonen.2007.3032">Hakonen et al 2007</xref>]. This close biologic relationship explains the phenotypic overlap of the disorders caused by <italic toggle="yes">TWNK</italic> pathogenic variants and the disorders caused by <italic toggle="yes">POLG</italic> pathogenic variants. Of note, disorders caused by <italic toggle="yes">POLG</italic> pathogenic variants are more common than disorders caused by <italic toggle="yes">TWNK</italic> pathogenic variants.</p>
        <p>The syndromes associated with autosomal recessive <italic toggle="yes">POLG</italic> pathogenic variants range from an infantile hepatoencephalopathy (Alpers-Huttenlocher syndrome) [<xref ref-type="bibr" rid="sca-io.REF.ferrari.2005.723">Ferrari et al 2005</xref>, <xref ref-type="bibr" rid="sca-io.REF.nguyen.2005.1493">Nguyen et al 2005</xref>] to a mitochondrial spinocerebellar ataxia-epilepsy syndrome (MSCAE; also called MIRAS [<italic toggle="yes">mi</italic>tochondrial <italic toggle="yes">r</italic>ecessive <italic toggle="yes">a</italic>taxia <italic toggle="yes">s</italic>yndrome]) [<xref ref-type="bibr" rid="sca-io.REF.hakonen.2005.430">Hakonen et al 2005</xref>, <xref ref-type="bibr" rid="sca-io.REF.tzoulis.2006.1685">Tzoulis et al 2006</xref>, <xref ref-type="bibr" rid="sca-io.REF.engelsen.2008.818">Engelsen et al 2008</xref>].</p>
        <list list-type="bullet">
          <list-item>
            <p>Early encephalopathy, sensory axonal neuropathy, epilepsy, and signs of hepatopathy with mtDNA depletion in the liver are seen in <italic toggle="yes">TWNK</italic> compound heterozygotes (atypical IOSCA), in the three individuals with the recessive <italic toggle="yes">TWNK</italic> pathogenic variant <xref ref-type="table" rid="sca-io.T.selected_twnk_c10orf2_pathogeni">c.1370C&#x0003e;T</xref>, and in individuals with <italic toggle="yes">POLG</italic>-associated Alpers-Huttenlocher syndrome [<xref ref-type="bibr" rid="sca-io.REF.hakonen.2007.3032">Hakonen et al 2007</xref>, <xref ref-type="bibr" rid="sca-io.REF.sarzi.2007.579">Sarzi et al 2007</xref>].</p>
          </list-item>
          <list-item>
            <p>While IOSCA and MSCAE share clinical features, spinocerebellar degeneration starts earlier and progresses faster in IOSCA than in MSCAE [<xref ref-type="bibr" rid="sca-io.REF.koskinen.1994a.509">Koskinen et al 1994a</xref>, <xref ref-type="bibr" rid="sca-io.REF.l_nnqvist.1998.57">L&#x000f6;nnqvist et al 1998</xref>, <xref ref-type="bibr" rid="sca-io.REF.hakonen.2007.3032">Hakonen et al 2007</xref>, <xref ref-type="bibr" rid="sca-io.REF.hakonen.2008.3822">Hakonen et al 2008</xref>].</p>
          </list-item>
        </list>
        <p><related-object link-type="booklink" source-id="gene" document-id="ataxia-telangiectas" document-type="chapter"><bold>Ataxia-telangiectasia</bold></related-object>
<bold>(A-T)</bold> is characterized by progressive cerebellar ataxia beginning between age one and four years, oculomotor apraxia, frequent infections, choreoathetosis, telangiectasias of the conjunctivae, immunodeficiency, and an increased risk for malignancy, particularly leukemia and lymphoma. Individuals with A-T are unusually sensitive to ionizing radiation.</p>
        <p>Diagnosis of A-T relies on clinical findings, including slurred speech, truncal ataxia, oculomotor apraxia, family history, and neuroimaging. Testing that supports the diagnosis includes serum alphafetoprotein concentration (elevated in &#x0003e;95% of individuals with A-T), identification of a 7;14 chromosome translocation on routine karyotype of peripheral blood, the presence of immunodeficiency, and in vitro radiosensitivity assay. A-T is caused by pathogenic variants in <italic toggle="yes">ATM</italic>. If the clinical diagnosis can be established with certainty and the specific pathogenic variants cannot be identified in an affected family member, linkage analysis may be used for genetic counseling of at-risk family members.</p>
        <p>IOSCA is distinguished from A-T by: normal chromosome studies, normal immune function, loss of deep-tendon reflexes, early ophthalmoplegia, and deafness; and by absence of telangiectasias.</p>
      </sec>
      <sec id="sca-io.Management">
        <title>Management</title>
        <sec id="sca-io.Evaluations_Following_Initial_Dia">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with infantile-onset spinocerebellar ataxia (IOSCA), the following are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Neurologic examination</bold> to evaluate the grade of ataxia and neuropathy</p>
            </list-item>
            <list-item>
              <p><bold>Audiologic examination</bold> to evaluate the grade of hearing deficit and need for hearing aids</p>
            </list-item>
            <list-item>
              <p><bold>Ophthalmologic examination</bold> to evaluate the grade of ophthalmoparesis and optic atrophy</p>
            </list-item>
            <list-item>
              <p>
                <bold>Neurophysiologic examinations</bold>
              </p>
              <list list-type="bullet">
                <list-item>
                  <p>ENMG (electroneuromyography)</p>
                </list-item>
                <list-item>
                  <p>SEP (somatosensory evoked potentials). Note: Changes in SEP occur early in the disease course and correlate with sensory system involvement.</p>
                </list-item>
                <list-item>
                  <p>VEP (visual evoked potentials)</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>Neuroimaging.</bold> Brain MRI</p>
            </list-item>
            <list-item>
              <p><bold>Other.</bold> Clinical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="sca-io.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Treatment is symptomatic:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Deafness.</bold> Hearing aids, speech therapy, and sign language to support social adaptation and prevent educational problems in children with IOSCA. Computers may be a valuable aid in support of communication and learning.</p>
            </list-item>
            <list-item>
              <p><bold>Sensory axonal neuropathy.</bold> Physiotherapy and orthoses to prevent foot and spine deformity; supportive shoes, splints, and braces; orthopedic surgery for foot deformities (pes cavus) and spine deformities (scoliosis); foot care to treat calluses and ulcerations</p>
            </list-item>
            <list-item>
              <p><bold>Ataxia.</bold> A walker, wheelchair, physiotherapy, occupational therapy</p>
            </list-item>
            <list-item>
              <p><bold>Epilepsy.</bold> Conventional antiepileptic drugs (AEDs) (phenytoin and phenobarbital) are ineffective in most patients [<xref ref-type="bibr" rid="sca-io.REF.l_nnqvist.2009.1553">L&#x000f6;nnqvist et al 2009</xref>].</p>
              <list list-type="bullet">
                <list-item>
                  <p>Some patients have benefited from lamotrigine or levetiracetam.</p>
                </list-item>
                <list-item>
                  <p>Benzodiazepines, especially midazolam-infusion, when started early in status epilepticus, were occasionally effective.</p>
                </list-item>
                <list-item>
                  <p>Oxcarbazepine has some effect, but hyponatremia is a troublesome side effect.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>Psychiatric symptoms.</bold> Antipsychotics (neurolepts, risperidone, olanzpine) to prevent psychotic behavior and antidepressants (SSRIs) for severe depression</p>
            </list-item>
          </list>
        </sec>
        <sec id="sca-io.Surveillance">
          <title>Surveillance</title>
          <p>
            <bold>Small children</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Neurologic, audiologic, and ophthalmologic evaluation every six to 12 months</p>
            </list-item>
            <list-item>
              <p>Neurophysiologic studies when clinically indicated</p>
            </list-item>
            <list-item>
              <p>Brain MRI every three to five years</p>
            </list-item>
          </list>
          <p>
            <bold>Adolescents and adults</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Neurologic examination annually</p>
            </list-item>
            <list-item>
              <p>Audiologic and ophthalmologic examinations every one to two years</p>
            </list-item>
            <list-item>
              <p>EEG and brain MRI at least during status epilepticus</p>
            </list-item>
          </list>
        </sec>
        <sec id="sca-io.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Valproate is contraindicated in patients with IOSCA, as it is in other disorders that potentially affect mitochondrial function in liver. Valproate caused significant elevation of liver enzymes (alanine aminotransferase [ALAT] 232 units/L [normal: 10-35 U/L] and gamma-GT [GGT] 160 U/L [normal: 5-50 U/L]) and icterus with elevated bilirubin levels (total: 224 &#x000b5;mol/L [normal: 5-25 &#x000b5;mol/L]; conjugated: 160 &#x000b5;mol/L [normal:1-8 &#x000b5;mol/L]) in one patient, and similar elevation of liver transaminases in another. When valproate was discontinued, icterus disappeared and the liver enzymes normalized.</p>
        </sec>
        <sec id="sca-io.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="sca-io.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="sca-io.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="sca-io.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="sca-io.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Infantile-onset spinocerebellar ataxia (IOSCA) is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="sca-io.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected individual are obligate heterozygotes (i.e., carriers of one <italic toggle="yes">TWNK</italic> [<italic toggle="yes">C10orf2</italic>] pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Once an at-risk sib is known to be unaffected, the risk of his/her being a carrier of one <italic toggle="yes">TWNK</italic> pathogenic variant is 2/3.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Individuals with IOSCA do not reproduce. Females with IOSCA have hypergonadotropic hypogonadism, indicative of ovarian failure. Males with IOSCA are too severely disabled to reproduce [<xref ref-type="bibr" rid="sca-io.REF.koskinen.1995a.263">Koskinen et al 1995a</xref>].</p>
          <p><bold>Other family members of a proband.</bold> Each sib of the proband&#x02019;s parents is at 50% risk of being a carrier of a <italic toggle="yes">TWNK</italic> pathogenic variant.</p>
        </sec>
        <sec id="sca-io.Carrier_Detection">
          <title>Carrier Detection</title>
          <p>Carrier testing for at-risk relatives requires prior identification of the <italic toggle="yes">TWNK</italic> pathogenic variants in the family.</p>
        </sec>
        <sec id="sca-io.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are carriers or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="sca-io.Prenatal_Testing_and_Preimplantat">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">TWNK</italic> pathogenic variants have been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for IOSCA are possible.</p>
        </sec>
      </sec>
      <sec id="sca-io.Resources">
        <title>Resources</title>
      </sec>
      <sec id="sca-io.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="sca-io.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>Infantile-onset spinocerebellar ataxia (IOSCA) is caused by pathogenic variants in <italic toggle="yes">TWNK</italic> (<italic toggle="yes">C10orf2</italic>), a ubiquitously expressed nuclear gene encoding mitochondrial protein isoforms Twinkle and Twinky [<xref ref-type="bibr" rid="sca-io.REF.nikali.2005.2981">Nikali et al 2005</xref>].</p>
          <p><bold>Gene structure.</bold> The longest <italic toggle="yes">TWNK</italic> transcript comprises five exons, which encode the major splice variant Twinkle (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_021830.4">NM_021830.4</ext-link>; 3640 bp). Transcript variant <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_001163812.1">NM_001163812.1</ext-link> is a minor splice variant that encodes the protein known as Twinky (AF292005; 3684 bp).</p>
          <p>This cDNA results from the use of a downstream exon 4 splice-donor site and leads to a 43-base-pair (bp) insertion between the regular exon 4-exon 5 sequence, which causes a premature stop codon [<xref ref-type="bibr" rid="sca-io.REF.spelbrink.2001.223">Spelbrink et al 2001</xref>]. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="sca-io" object-id="sca-io.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p><bold>Pathogenic variants</bold> (see <xref ref-type="table" rid="sca-io.T.selected_twnk_c10orf2_pathogeni">Table 2</xref>)</p>
          <list list-type="bullet">
            <list-item>
              <p>Most individuals with IOSCA (88%; 21/24) are homozygous for the IOSCA founder variant c.1523A&#x0003e;G in exon 3 of <italic toggle="yes">TWNK</italic>, which changes tyrosine to cysteine (p.Tyr508Cys) in the corresponding proteins Twinkle and Twinky [<xref ref-type="bibr" rid="sca-io.REF.nikali.2005.2981">Nikali et al 2005</xref>].</p>
            </list-item>
            <list-item>
              <p>One individual affected with IOSCA is a compound heterozygote with the c.1523A&#x0003e;G pathogenic variant in his maternal <italic toggle="yes">TWNK</italic> allele and a synonymous c.1287C&#x0003e;T transition in exon 2 in his paternal <italic toggle="yes">TWNK</italic> allele. The silent c.1287C&#x0003e;T transition variant reduces the allelic expression level to 2.6 times lower than normal [<xref ref-type="bibr" rid="sca-io.REF.nikali.2005.2981">Nikali et al 2005</xref>].</p>
            </list-item>
            <list-item>
              <p>Two individuals with IOSCA with a slightly different phenotype are compound heterozygotes for the founder c.1523A&#x0003e;G variant and a novel c.952G&#x0003e;A variant [<xref ref-type="bibr" rid="sca-io.REF.hakonen.2007.3032">Hakonen et al 2007</xref>].</p>
            </list-item>
            <list-item>
              <p>All pathogenic variants underlying IOSCA have been observed only in the genetically isolated Finnish population.</p>
            </list-item>
            <list-item>
              <p>The c.1287C&#x0003e;T pathogenic variant was observed in an affected individual who was a compound heterozygote with the second allele having the c.1523A&#x0003e;G pathogenic variant. The c.1287C&#x0003e;T allele was expressed at a reduced level as a result of an unknown mechanism [<xref ref-type="bibr" rid="sca-io.REF.nikali.2005.2981">Nikali et al 2005</xref>]. Reduced expression could be caused by the c.1287C&#x0003e;T variant or the variant could be in tight linkage disequilibrium with another unidentified pathogenic variant. The phenotype of this compound heterozygous individual was classic IOSCA.</p>
            </list-item>
          </list>
          <table-wrap id="sca-io.T.selected_twnk_c10orf2_pathogeni" orientation="portrait" position="anchor">
            <label>Table 2. </label>
            <caption>
              <p>Selected <italic toggle="yes">TWNK</italic> (<italic toggle="yes">C10orf2</italic>) Pathogenic Variants</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_sca-io.T.selected_twnk_c10orf2_pathogeni_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                  <th id="hd_h_sca-io.T.selected_twnk_c10orf2_pathogeni_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change<break/>(Alias&#x000a0;<sup>1</sup>)</th>
                  <th id="hd_h_sca-io.T.selected_twnk_c10orf2_pathogeni_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_sca-io.T.selected_twnk_c10orf2_pathogeni_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1523A&#x0003e;G</td>
                  <td headers="hd_h_sca-io.T.selected_twnk_c10orf2_pathogeni_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Tyr508Cys</td>
                  <td headers="hd_h_sca-io.T.selected_twnk_c10orf2_pathogeni_1_1_1_3" rowspan="5" valign="middle" align="left" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&#x00026;id=39725941">NM_021830.4</ext-link>
                    <break/>
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&#x00026;id=39725942">NP_068602.2</ext-link>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_sca-io.T.selected_twnk_c10orf2_pathogeni_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1287C&#x0003e;T</td>
                  <td headers="hd_h_sca-io.T.selected_twnk_c10orf2_pathogeni_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.=&#x000a0;<sup>2</sup><break/>(Ala429Ala)</td>
                </tr>
                <tr>
                  <td headers="hd_h_sca-io.T.selected_twnk_c10orf2_pathogeni_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.952G&#x0003e;A</td>
                  <td headers="hd_h_sca-io.T.selected_twnk_c10orf2_pathogeni_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ala318Thr</td>
                </tr>
                <tr>
                  <td headers="hd_h_sca-io.T.selected_twnk_c10orf2_pathogeni_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.955A&#x0003e;G&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_sca-io.T.selected_twnk_c10orf2_pathogeni_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Lys319Glu</td>
                </tr>
                <tr>
                  <td headers="hd_h_sca-io.T.selected_twnk_c10orf2_pathogeni_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1370C&#x0003e;T&#x000a0;<sup>4</sup></td>
                  <td headers="hd_h_sca-io.T.selected_twnk_c10orf2_pathogeni_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Thr457Ile</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
              </fn>
              <fn>
                <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
              </fn>
              <fn id="sca-io.TF.2.1">
                <label>1. </label>
                <p>Variant designation that does not conform to current naming conventions</p>
              </fn>
              <fn id="sca-io.TF.2.2">
                <label>2. </label>
                <p>p.(=) designates that the protein has not been analyzed, but no change is expected.</p>
              </fn>
              <fn id="sca-io.TF.2.3">
                <label>3. </label>
                <p>SANDO; see Genetically Related Disorders.</p>
              </fn>
              <fn id="sca-io.TF.2.4">
                <label>4. </label>
                <p>Hepatocerebral form of mtDNA depletion syndrome; see Genetically Related Disorders.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Normal gene product.</bold>
<italic toggle="yes">TWNK</italic> (<italic toggle="yes">C10orf2</italic>) was originally cloned and the proteins resulting from the variant splicing of the gene, Twinkle and Twinky, were characterized by <xref ref-type="bibr" rid="sca-io.REF.spelbrink.2001.223">Spelbrink et al [2001]</xref>. Twinkle and Twinky are nuclear-encoded evolutionarily conserved mitochondrial proteins, Twinkle being essentially involved in the maintenance of mtDNA.</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Twinkle.</bold> The major splice variant Twinkle consists of 684 amino acids with a molecular mass of 77 kd. Twinkle forms stable hexamers that localize to mitochondrial nucleoids, mtDNA-protein complexes within which the coupled replication and transcription of mtDNA takes place. Twinkle contains a 42-bp N-terminal mitochondrial localization signal, followed by a primase-related domain, primase-helicase linker region, and a C-terminal helicase domain. Twinkle is structurally related to the bacteriophage T7 gene 4 protein (primase/helicase) and is known to perform as an essential mtDNA-specific replicative helicase. Twinkle homologs have been observed at least in <italic toggle="yes">Plasmodium chabaudi chabaudi</italic>, <italic toggle="yes">Caenorhabditis elegans,</italic> and <italic toggle="yes">Drosophila melanogaster,</italic> but not in <italic toggle="yes">Saccharomyces cerevisiae</italic> [<xref ref-type="bibr" rid="sca-io.REF.spelbrink.2001.223">Spelbrink et al 2001</xref>].</p>
              <p>As a mtDNA-specific helicase, Twinkle catalyzes ATP-dependent unwinding of duplex DNA with 5&#x02019;&#x02192;3&#x02019; polarity [<xref ref-type="bibr" rid="sca-io.REF.korhonen.2003.48627">Korhonen et al 2003</xref>]. Its functional partner is mtDNA-polymerase gamma (POLG), with which it creates a processive replication machinery to use double-stranded DNA (dsDNA) as a template for single-stranded DNA (ssDNA) synthesis [<xref ref-type="bibr" rid="sca-io.REF.korhonen.2004.2423">Korhonen et al 2004</xref>]. In the carboxyl terminus, critical residues between amino acids 572 and 596 of the 613-amino acid polypeptide are essential for mtDNA helicase function in vivo, as shown in <italic toggle="yes">Drosophila</italic> cell cultures [<xref ref-type="bibr" rid="sca-io.REF.matsushima.2008.23964">Matsushima et al 2008</xref>]. The N-terminal part of Twinkle is needed for efficient binding to ssDNA. Truncations in this region reduce both helicase activity and functional efficacy of the mtDNA replisome [<xref ref-type="bibr" rid="sca-io.REF.farge.2008.393">Farge et al 2008</xref>].</p>
              <p>In addition to being essential for mtDNA integrity, Twinkle regulates mtDNA copy number, as shown by analyzing overexpression of wild-type Twinkle in mice and human osteosarcoma cell lines [<xref ref-type="bibr" rid="sca-io.REF.tyynismaa.2004.3219">Tyynismaa et al 2004</xref>]. In the mice, increased expression of Twinkle in muscle and heart resulted in a threefold increase in mtDNA copy number. In cultured human cells, reducing Twinkle expression by RNA interference mediated a rapid drop in mtDNA copy number.</p>
              <p>Phylogenetic analyses showed that Twinkle is widespread in the eukaryotic radiation and suggested that it may also function as a primase [<xref ref-type="bibr" rid="sca-io.REF.shutt.2006.588">Shutt &#x00026; Gray 2006</xref>]. Indeed, the minimal mtDNA replisome consisting of Twinkle, POLG, and mitochondrial single-strand binding protein (mtSSB) can support leading-strand mtDNA synthesis on a dsDNA template in vitro [<xref ref-type="bibr" rid="sca-io.REF.korhonen.2004.2423">Korhonen et al 2004</xref>], but human mitochondrial RNA polymerase primes lagging-strand synthesis in vitro [<xref ref-type="bibr" rid="sca-io.REF.wanrooij.2008.11122">Wanrooij et al 2008</xref>].</p>
              <p>The primase/helicase linker region of Twinkle is essential for hexamer formation, which is required for the ATP-hydrolyzing activity and DNA unwinding. Supposedly, the linker region interacts with amino acids in the helicase domain of the adjacent monomer to form functional multimers [<xref ref-type="bibr" rid="sca-io.REF.korhonen.2008.691">Korhonen et al 2008</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Twinky.</bold> Approximately 20% of the <italic toggle="yes">TWNK</italic> transcripts in human lymphoblasts code for the minor splice variant Twinky [<xref ref-type="bibr" rid="sca-io.REF.nikali.2005.2981">Nikali et al 2005</xref>; Nikali, unpublished data]. Twinky presents as a 66-kd product of 582 amino acids, lacking residues 579-684, as compared to Twinkle, and terminating with four unique amino acids. Twinky presents as a monomer, is located diffusely within mitochondria, and shows no helicase activity [<xref ref-type="bibr" rid="sca-io.REF.spelbrink.2001.223">Spelbrink et al 2001</xref>]. The function of Twinky remains unknown.</p>
            </list-item>
          </list>
          <p><bold>Abnormal gene product.</bold> The cellular pathogenesis of IOSCA originally remained largely unresolved, and current research has focused mainly on the major splice variant Twinkle and the founder c.1523A&#x0003e;G (p.Tyr508Cys) variant, even though the pathogenic variant is also present in the Twinky protein.</p>
          <p>The behavior and function of the Twinkle protein isoform with the p.Tyr508Cys pathogenic variant are described:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>In general.</bold> The founder IOSCA variant (p.Tyr508Cys) is located in the helicase domain of Twinkle, just upstream of a conserved Walker B motif involved in dNTP binding [<xref ref-type="bibr" rid="sca-io.REF.nikali.2005.2981">Nikali et al 2005</xref>]. It creates a conserved CXXCH-heme binding motif, observed in b-type cytochromes, but Twinkle-p.Tyr508Cys does not bind heme covalently [<xref ref-type="bibr" rid="sca-io.REF.hakonen.2008.3822">Hakonen et al 2008</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Integrity of mtDNA.</bold> In IOSCA, mtDNA stays intact, with no deletions or increased number of single-nucleotide variants (SNVs) observed in all tissues analyzed, including the brain [<xref ref-type="bibr" rid="sca-io.REF.nikali.2005.2981">Nikali et al 2005</xref>, <xref ref-type="bibr" rid="sca-io.REF.hakonen.2008.3822">Hakonen et al 2008</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>In vitro.</bold> The founder IOSCA variant (p.Tyr508Cys) does not alter the subcellular localization or half-life of either Twinkle or Twinky [<xref ref-type="bibr" rid="sca-io.REF.nikali.2005.2981">Nikali et al 2005</xref>]. Also helicase activity, hexamerization, and nucleoid structure remain normal [<xref ref-type="bibr" rid="sca-io.REF.hakonen.2008.3822">Hakonen et al 2008</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>In the brain of an individual affected with IOSCA.</bold> In post-mortem examination of an individual with IOSCA, the cerebellum and cerebrum showed mtDNA depletion (residual amounts 5%-20%), but did not harbor mtDNA deletions or a greater number of mtDNA SNVs. The cerebellar Purkinje and pyramidal cells showed reduced levels of respiratory chain complex I, and the large neurons of frontal cortex showed reduced levels of both complexes I and IV. IOSCA is associated with brain-specific depletion of mtDNA and reduced respiratory chain enzyme activities and can be concluded as a novel mtDNA depletion syndrome [<xref ref-type="bibr" rid="sca-io.REF.hakonen.2008.3822">Hakonen et al 2008</xref>]. However, the mechanism by which the p.Tyr508Cys pathogenic variant in Twinkle causes mtDNA depletion remains to be investigated.</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec id="sca-io.References">
        <title>References</title>
        <sec id="sca-io.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="sca-io.Literature_Cited.reflist0">
            <ref id="sca-io.REF.baloh.2007.998">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Baloh</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salavaggione</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milbrandt</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pestronk</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Familial parkinsonism and ophthalmoplegia from a mutation in the mitochondrial DNA helicase twinkle.</article-title>
                <source>Arch Neurol</source>
                <volume>64</volume>
                <fpage>998</fpage>
                <lpage>1000</lpage>
                <pub-id pub-id-type="pmid">17620490</pub-id>
              </element-citation>
            </ref>
            <ref id="sca-io.REF.bohlega.2009.845">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bohlega</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Goethem</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al Semari</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000f6;fgren</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al Hamed</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Broeckhoven</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kambouris</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Novel Twinkle gene mutation in autosomal dominant progressive external ophthalmoplegia and multisystem failure.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>19</volume>
                <fpage>845</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">19853444</pub-id>
              </element-citation>
            </ref>
            <ref id="sca-io.REF.engelsen.2008.818">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Engelsen</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tzoulis</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karlsen</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lilleb&#x000f8;</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laegreid</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aasly</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeviani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bindoff</surname>
                    <given-names>LA</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>POLG1 mutations cause a syndromic epilepsy with occipital lobe predilection.</article-title>
                <source>Brain</source>
                <volume>131</volume>
                <fpage>818</fpage>
                <lpage>28</lpage>
                <pub-id pub-id-type="pmid">18238797</pub-id>
              </element-citation>
            </ref>
            <ref id="sca-io.REF.farge.2008.393">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Farge</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holmlund</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khvorostova</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rofougaran</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hofer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Falkenberg</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>The N-terminal domain of TWINKLE contributes to single-stranded DNA binding and DNA helicase activities.</article-title>
                <source>Nucleic Acids Res</source>
                <volume>36</volume>
                <fpage>393</fpage>
                <lpage>403</lpage>
                <pub-id pub-id-type="pmid">18039713</pub-id>
              </element-citation>
            </ref>
            <ref id="sca-io.REF.ferrari.2005.723">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ferrari</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lamantea</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donati</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Filosto</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Briem</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carrara</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parini</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simonati</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santer</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeviani</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerase-gammaA.</article-title>
                <source>Brain.</source>
                <volume>128</volume>
                <fpage>723</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">15689359</pub-id>
              </element-citation>
            </ref>
            <ref id="sca-io.REF.hakonen.2008.3822">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hakonen</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goffart</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marjavaara</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paetau</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cooper</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mattila</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lampinen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sajantila</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000f6;nnqvist</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spelbrink</surname>
                    <given-names>JN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suomalainen</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Infantile-onset spinocerebellar ataxia and mitochondrial recessive ataxia syndrome are associated with neuronal complex I defect and mtDNA depletion.</article-title>
                <source>Hum Mol Genet</source>
                <volume>17</volume>
                <fpage>3822</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">18775955</pub-id>
              </element-citation>
            </ref>
            <ref id="sca-io.REF.hakonen.2005.430">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hakonen</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heiskanen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Juvonen</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lappalainen</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luoma</surname>
                    <given-names>PT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rantamaki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goethem</surname>
                    <given-names>GV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lofgren</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hackman</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paetau</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaakkola</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Majamaa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Varilo</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Udd</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaariainen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bindoff</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suomalainen</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Mitochondrial DNA polymerase W748S mutation: a common cause of autosomal recessive ataxia with ancient European origin.</article-title>
                <source>Am J Hum Genet</source>
                <volume>77</volume>
                <fpage>430</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">16080118</pub-id>
              </element-citation>
            </ref>
            <ref id="sca-io.REF.hakonen.2007.3032">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hakonen</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Isohanni</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paetau</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herva</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suomalainen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000f6;nnqvist</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Recessive Twinkle mutations in early onset encephalopathy with mtDNA depletion.</article-title>
                <source>Brain</source>
                <volume>130</volume>
                <fpage>3032</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">17921179</pub-id>
              </element-citation>
            </ref>
            <ref id="sca-io.REF.hudson.2005.371">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hudson</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deschauer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Busse</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zierz</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Sensory ataxic neuropathy due to a novel C10Orf2 mutation with probable germline mosaicism.</article-title>
                <source>Neurology</source>
                <volume>64</volume>
                <fpage>371</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">15668446</pub-id>
              </element-citation>
            </ref>
            <ref id="sca-io.REF.jeppesen.2008.306">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jeppesen</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colding-J&#x000f8;rgensen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krag</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hauerslev</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vissing</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Phenotype and clinical course in a family with a new de novo Twinkle gene mutation.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>18</volume>
                <fpage>306</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">18396044</pub-id>
              </element-citation>
            </ref>
            <ref id="sca-io.REF.kallio.1985.84">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kallio</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jauhiainen</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>1985</year>
                <article-title>A new syndrome of ophthalmoplegia, hypoacusis, ataxia, hypotonia and athetosis (OHAHA).</article-title>
                <source>Adv Audiol</source>
                <volume>3</volume>
                <fpage>84</fpage>
                <lpage>90</lpage>
              </element-citation>
            </ref>
            <ref id="sca-io.REF.kiechl.2004.1125">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kiechl</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horv&#x000e1;th</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luoma</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kiechl-Kohlendorfer</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallacher-Scholz</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stucka</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thaler</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wanschitz</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suomalainen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaksch</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willeit</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Two families with autosomal dominant progressive external ophthalmoplegia.</article-title>
                <source>J Neurol Neurosurg Psychiatry</source>
                <volume>75</volume>
                <fpage>1125</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15258213</pub-id>
              </element-citation>
            </ref>
            <ref id="sca-io.REF.korhonen.2003.48627">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Korhonen</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaspari</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Falkenberg</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>TWINKLE has 5' -&#x0003e; 3' DNA helicase activity and is specifically stimulated by mitochondrial single-stranded DNA-binding protein.</article-title>
                <source>J Biol Chem</source>
                <volume>278</volume>
                <fpage>48627</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">12975372</pub-id>
              </element-citation>
            </ref>
            <ref id="sca-io.REF.korhonen.2008.691">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Korhonen</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pande</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holmlund</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farge</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pham</surname>
                    <given-names>XH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nilsson</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Falkenberg</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Structure-function defects of the TWINKLE linker region in progressive external ophthalmoplegia.</article-title>
                <source>J Mol Biol</source>
                <volume>377</volume>
                <fpage>691</fpage>
                <lpage>705</lpage>
                <pub-id pub-id-type="pmid">18279890</pub-id>
              </element-citation>
            </ref>
            <ref id="sca-io.REF.korhonen.2004.2423">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Korhonen</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pham</surname>
                    <given-names>XH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pellegrini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Falkenberg</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Reconstitution of a minimal mtDNA replisome in vitro.</article-title>
                <source>EMBO J</source>
                <volume>23</volume>
                <fpage>2423</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15167897</pub-id>
              </element-citation>
            </ref>
            <ref id="sca-io.REF.koskinen.1995a.263">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Koskinen</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pihko</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Voutilainen</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>1995a</year>
                <article-title>Primary hypogonadism in females with infantile onset spinocerebellar ataxia.</article-title>
                <source>Neuropediatrics</source>
                <volume>26</volume>
                <fpage>263</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">8552218</pub-id>
              </element-citation>
            </ref>
            <ref id="sca-io.REF.koskinen.1994a.509">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Koskinen</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sainio</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rapola</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pihko</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paetau</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1994a</year>
                <article-title>Sensory neuropathy in infantile onset spinocerebellar ataxia (IOSCA).</article-title>
                <source>Muscle Nerve</source>
                <volume>17</volume>
                <fpage>509</fpage>
                <lpage>15</lpage>
                <pub-id pub-id-type="pmid">8159181</pub-id>
              </element-citation>
            </ref>
            <ref id="sca-io.REF.koskinen.1994b.50">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Koskinen</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santavuori</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sainio</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lappi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kallio</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pihko</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>1994b</year>
                <article-title>Infantile onset spinocerebellar ataxia with sensory neuropathy: a new inherited disease.</article-title>
                <source>J Neurol Sci</source>
                <volume>121</volume>
                <fpage>50</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">8133312</pub-id>
              </element-citation>
            </ref>
            <ref id="sca-io.REF.koskinen.1995b.1427">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Koskinen</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valanne</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ketonen</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pihko</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>1995b</year>
                <article-title>Infantile-onset spinocerebellar ataxia: MR and CT findings.</article-title>
                <source>AJNR Am J Neuroradiol</source>
                <volume>16</volume>
                <fpage>1427</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">7484627</pub-id>
              </element-citation>
            </ref>
            <ref id="sca-io.REF.l_nnqvist.1998.57">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>L&#x000f6;nnqvist</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paetau</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nikali</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von Boguslawski</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pihko</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Infantile onset spinocerebellar ataxia with sensory neuropathy (IOSCA): neuropathological features.</article-title>
                <source>J Neurol Sci</source>
                <volume>161</volume>
                <fpage>57</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">9879682</pub-id>
              </element-citation>
            </ref>
            <ref id="sca-io.REF.l_nnqvist.2009.1553">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>L&#x000f6;nnqvist</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paetau</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valanne</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pihko</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Recessive Twinkle mutations cause severe epileptic encephalopathy.</article-title>
                <source>Brain</source>
                <volume>132</volume>
                <fpage>1553</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">19304794</pub-id>
              </element-citation>
            </ref>
            <ref id="sca-io.REF.matsushima.2008.23964">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Matsushima</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farr</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fan</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaguni</surname>
                    <given-names>LS</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Physiological and Biochemical Defects in Carboxyl-terminal Mutants of Mitochondrial DNA Helicase.</article-title>
                <source>J Biol Chem</source>
                <volume>283</volume>
                <fpage>23964</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">18593709</pub-id>
              </element-citation>
            </ref>
            <ref id="sca-io.REF.nguyen.2005.1493">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nguyen</surname>
                    <given-names>KV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>&#x000d8;stergaard</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ravn</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balslev</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Danielsen</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vardag</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKiernan</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gray</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naviaux</surname>
                    <given-names>RK</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>POLG mutations in Alpers syndrome.</article-title>
                <source>Neurology</source>
                <volume>65</volume>
                <fpage>1493</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">16177225</pub-id>
              </element-citation>
            </ref>
            <ref id="sca-io.REF.nikali.2005.2981">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nikali</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suomalainen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saharinen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuokkanen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spelbrink</surname>
                    <given-names>JN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000f6;nnqvist</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peltonen</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Infantile onset spinocerebellar ataxia is caused by recessive mutations in mitochondrial proteins Twinkle and Twinky.</article-title>
                <source>Hum Mol Genet</source>
                <volume>14</volume>
                <fpage>2981</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">16135556</pub-id>
              </element-citation>
            </ref>
            <ref id="sca-io.REF.nikali.1995.1088">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nikali</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suomalainen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terwilliger</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koskinen</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weissenbach</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peltonen</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Random search for shared chromosomal regions in four affected individuals: the assignment of a new hereditary ataxia locus.</article-title>
                <source>Am J Hum Genet</source>
                <volume>56</volume>
                <fpage>1088</fpage>
                <lpage>95</lpage>
                <pub-id pub-id-type="pmid">7726163</pub-id>
              </element-citation>
            </ref>
            <ref id="sca-io.REF.park.2014.171">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woo</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hong</surname>
                    <given-names>YB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoon</surname>
                    <given-names>BR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoo</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koo</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chae</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chung</surname>
                    <given-names>KW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choi</surname>
                    <given-names>BO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koo</surname>
                    <given-names>SK</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Recessive C10orf2 mutations in a family with infantile-onset spinocerebellar ataxia, sensorimotor polyneuropathy, and myopathy.</article-title>
                <source>Neurogenetics</source>
                <volume>15</volume>
                <fpage>171</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">24816431</pub-id>
              </element-citation>
            </ref>
            <ref id="sca-io.REF.rivera.2007.677">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rivera</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bl&#x000e1;zquez</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carretero</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alvarez-Cerme&#x000f1;o</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campos</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cabello</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonzalez-Vioque</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borstein</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garesse</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arenas</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mart&#x000ed;n</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Mild ocular myopathy associated with a novel mutation in mitochondrial twinkle helicase.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>17</volume>
                <fpage>677</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">17614277</pub-id>
              </element-citation>
            </ref>
            <ref id="sca-io.REF.sarzi.2007.579">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sarzi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goffart</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Serre</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chr&#x000e9;tien</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slama</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munnich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spelbrink</surname>
                    <given-names>JN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>R&#x000f6;tig</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Twinkle helicase (PEO1) gene mutation causes mitochondrial DNA depletion.</article-title>
                <source>Ann Neurol</source>
                <volume>62</volume>
                <fpage>579</fpage>
                <lpage>87</lpage>
                <pub-id pub-id-type="pmid">17722119</pub-id>
              </element-citation>
            </ref>
            <ref id="sca-io.REF.shutt.2006.588">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shutt</surname>
                    <given-names>TE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gray</surname>
                    <given-names>MW</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Twinkle, the mitochondrial replicative DNA helicase, is widespread in the eukaryotic radiation and may also be the mitochondrial DNA primase in most eukaryotes.</article-title>
                <source>J Mol Evol</source>
                <volume>62</volume>
                <fpage>588</fpage>
                <lpage>99</lpage>
                <pub-id pub-id-type="pmid">16612544</pub-id>
              </element-citation>
            </ref>
            <ref id="sca-io.REF.spelbrink.2001.223">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Spelbrink</surname>
                    <given-names>JN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>FY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tiranti</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nikali</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yuan</surname>
                    <given-names>QP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tariq</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wanrooij</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garrido</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Comi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morandi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santoro</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toscano</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fabrizi</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Somer</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Croxen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beeson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poulton</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suomalainen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jacobs</surname>
                    <given-names>HT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeviani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larsson</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria.</article-title>
                <source>Nat Genet</source>
                <volume>28</volume>
                <fpage>223</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">11431692</pub-id>
              </element-citation>
            </ref>
            <ref id="sca-io.REF.suomalainen.1992.61">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Suomalainen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Majander</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haltia</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Somer</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000f6;nnqvist</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savontaus</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peltonen</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>1992</year>
                <article-title>Multiple deletions of mitochondrial DNA in several tissues of a patient with severe retarded depression and familial progressive external ophthalmoplegia.</article-title>
                <source>J Clin Invest</source>
                <volume>90</volume>
                <fpage>61</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">1634620</pub-id>
              </element-citation>
            </ref>
            <ref id="sca-io.REF.tyynismaa.2004.3219">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tyynismaa</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sembongi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bokori-Brown</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Granycome</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashley</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poulton</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jalanko</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spelbrink</surname>
                    <given-names>JN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holt</surname>
                    <given-names>IJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suomalainen</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Twinkle helicase is essential for mtDNA maintenance and regulates mtDNA copy number.</article-title>
                <source>Hum Mol Genet</source>
                <volume>13</volume>
                <fpage>3219</fpage>
                <lpage>27</lpage>
                <pub-id pub-id-type="pmid">15509589</pub-id>
              </element-citation>
            </ref>
            <ref id="sca-io.REF.tzoulis.2006.1685">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tzoulis</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engelsen</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Telstad</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aasly</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeviani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winterthun</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrari</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aarseth</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bindoff</surname>
                    <given-names>LA</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases.</article-title>
                <source>Brain</source>
                <volume>129</volume>
                <fpage>1685</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">16638794</pub-id>
              </element-citation>
            </ref>
            <ref id="sca-io.REF.virgilio.2008.1384">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Virgilio</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ronchi</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hadjigeorgiou</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bordoni</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saladino</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moggio</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adobbati</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kafetsouli</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsironi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Previtali</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papadimitriou</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bresolin</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Comi</surname>
                    <given-names>GP</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Novel Twinkle (PEO1) gene mutations in mendelian progressive external ophthalmoplegia.</article-title>
                <source>J Neurol</source>
                <volume>255</volume>
                <fpage>1384</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">18575922</pub-id>
              </element-citation>
            </ref>
            <ref id="sca-io.REF.wanrooij.2008.11122">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wanrooij</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fust&#x000e9;</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farge</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gustafsson</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Falkenberg</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Human mitochondrial RNA polymerase primes lagging-strand DNA synthesis in vitro.</article-title>
                <source>Proc Natl Acad Sci USA</source>
                <volume>105</volume>
                <fpage>11122</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">18685103</pub-id>
              </element-citation>
            </ref>
            <ref id="sca-io.REF.zeviani.1989.309">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zeviani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Servidei</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gellera</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiDonato</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1989</year>
                <article-title>An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region.</article-title>
                <source>Nature</source>
                <volume>339</volume>
                <fpage>309</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">2725645</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="sca-io.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="sca-io.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>15 January 2015 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>22 July 2010 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>27 January 2009 (me) Review posted live</p>
            </list-item>
            <list-item>
              <p>17 September 2008 (kn) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
